Yao et al. found that lncRNAs (A2M-AS1, C2orf27A, and ZNF667-AS1) targeted ferroptosis-related genes and impaired the activation of CD4+ T cells in GC, which provides a new strategy of GC immunotherapy (Yao et al., 2021). This evidence concerns the gene ZNF667 and gastric cancer.